Ocugen

News

A woman hides her face behind her hands, revealing her right eye

Ocugen shares fall, despite positive eye disorder trial

A trial of Ocugen's gene therapy for sight-robbing disease geographic atrophy (GA) showed efficacy – but still sparked a selloff in its shares.

News

Ocugen preps filings for COVID-19 vaccine Covaxin on new dat...

Armed with new data from its development partner Bharat Biotech, Ocugen is planning to press ahead with plans to file for approval of their COVID-19 vaccine Covaxin in the US and Canada.

News

Ocugen gets a black eye as FDA denies emergency OK for COVID...

Ocugen is the first company to be affected by the FDA's recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of i

News

Ocugen, Histogenics merge to form eye disease specialist

US biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies for ocular diseases.

Ocugen shares fall, despite positive eye disorder trial

Ocugen preps filings for COVID-19 vaccine Covaxin on new dat...

Ocugen gets a black eye as FDA denies emergency OK for COVID...

Ocugen, Histogenics merge to form eye disease specialist

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

Ocugen

Editor's Picks